Skip to main content

Clinical Trials › NCT04075266

Active, Not RecruitingPhase 2

A Study of Ocrelizumab in Children and Adolescents With Relapsing-Remitting Multiple Sclerosis

Sponsored by Hoffmann-La Roche

Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov
23
Target enrollment
5
U.S. states
Jan 2020
Start date
Dec 2029
Expected completion

Interventions / Treatments

Ocrelizumab

Conditions studied

Multiple Sclerosis

Where this trial is running (5 sites)

Colorado1 site
Aurora
Washington D.C.
Boston
Missouri1 site
St Louis
Ohio1 site
Cleveland

MS centers in Colorado

Compare treatment centers near a trial site by center type, providers and trials.

View Colorado centers

More Phase 2 trials

Browse all Phase 2 MS trials
The app

Check out the MS Buddy app

Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.

Download on the App StoreGet it on Google Play